부산대학교 도서관

Montesinos, P; Roboz, GJ; Bulabois, CE; Subklewe, M; Platzbecker, U; Ofran, Y; Papayannidis, C; Wierzbowska, A; Shin, HJ; Doronin, V; Deneberg, S; Yeh, SP; Ozcan, MA; Knapper, S; Cortes, J; Pollyea, DA; Ossenkoppele, G; Giralt, S; Dohner, H; Heuser, M; Xiu, L; Singh, I; Huang, F; Larsen, JS; Wei, ARH

Leukemia. 35(1):62-74

Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA.; Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy.; Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France.; Platzbecker U; University Hospital Leipzig, Leipzig, Germany.; Santini V; University of Florence, Florence, Italy.; Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain.; Singh A; Cleveland Clinic, Cleveland, OH, USA.; Jain AG; Cleveland Clinic, Cleveland, OH, USA.; Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA.; Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA.; Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Bennett JM; University of Rochester Medical Center, Rochester, NY, USA.; Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Bejar R; University of California San Diego, San Diego, CA, USA.; Carraway HE; Cleveland Clinic, Cleveland, OH, USA.; DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.; Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA.; Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; List AF; Precision BioSciences, Durham, NC, USA.; Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.; Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA.; Stahl M; Dana Farber Cancer Institute, Boston, MA, USA.; Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Steensma DP; Ajax Therapeutics, Cambridge, MA, USA.; Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA.; Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.; Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.; Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.; D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy.; Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.; Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.; Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.; Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.; Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Sanz G; Instituto de Salud Carlos III, Valencia, Spain.; Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain.; Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.; Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA.; Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rozman M; Hospital Clínic Barcelona, Barcelona, Spain.; Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain.; Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Foucar MK; University of New Mexico, Albuquerque, NM, USA.; Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.; Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.; Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil.; Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.; Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina.; Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK.; Cluzeau T; Nice University Hospital, Nice, France.; Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK.; van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands.; Ades L; Saint Louis Hospital, Paris Cité University, Paris, France.; Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Roboz GJ; Weill Medical College of Cornell University, New York, New York, United States.; Canaani J; Weill Medical College of Cornell University, New York, New York, United States.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.; Bennett JM; James P Wilmot Cancer Center and Division of Hematopathology, University of Rochester Medical Center, Rochester, NY, USA.; Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA.; Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Borate UM; Division of Haematology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Brunner AM; Division of Haematology, Massachusetts General Hospital Brigham, Boston, MA, USA.; Buckstein R; Department of Medical Oncology/ Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Churpek JE; Department of Haematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI.; Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA.; Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit, Rome, Italy.; Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France.; Figueroa ME; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gore SD; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA.; Greenberg PL; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.; Hourigan CS; Virginia Tech, Fralin Biomedical Research Institute, Cancer Research Center.; Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Kim N; NCI, NIH, Bethesda, Maryland.; Komrokji RS; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Kutchroo V; Brigham and Women's Hospital, Boston, MA, USA.; List AF; Precision BioSciences, Inc., Durham, NC, USA.; Little RF; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA.; Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.; Nimer SD; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.; Padron E; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Platzbecker U; Department of Haematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.; Della Porta MG; IRCCS Humanitas Research Hospital, Milan, Italy and Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USA.; Sallman DA; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Santini V; Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.; Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain.; Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Sekeres MA; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Starczynowski DT; Cincinnati Children's Hospital, Cincinnati, OH.; Steensma DP; David Steensma LLC, Cambridge, Massachusetts 02139, USA.; Taylor J; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Victoria, Australia.; Zhuoer X; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, MA, USA.; Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: Sloghavi@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Ghalehsari N; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York.; Castillo Tokumori F; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Chen Z; Division of Biostatistics, Department of Population Science, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Liu M; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York.; Mayer SA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Zeinah GA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Shore TB; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Ritchie EK; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Silver RT; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Scandura JM; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; Roboz GJ; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York.; van Besien K; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; UH Seidman Cancer Center, Cleveland, Ohio.; Gomez-Arteaga A; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York. Electronic address: alg9117@med.cornell.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

DiNardo CD; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.; Roboz GJ; Clinical and Translational Leukemia Programs, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.; Watts JM; Division of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.; Madanat YF; Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.; Prince GT; Division of Hematologic Malignancy, Johns Hopkins Hospital, Baltimore, MD.; Baratam P; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC.; de Botton S; Hematologie Clinique, Institut Gustave Roussy, Villejuif, Faculté Paris-Saclay, Institut Gustave Roussy, Villejuif, France.; Stein A; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.; Foran JM; Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL.; Arellano ML; Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.; Sallman DA; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Hossain M; Servier Pharmaceuticals, LLC, Boston, MA.; Marchione DM; Servier Pharmaceuticals, LLC, Boston, MA.; Bai X; Servier Pharmaceuticals, LLC, Boston, MA.; Patel PA; Servier Pharmaceuticals, LLC, Boston, MA.; Kapsalis SM; Servier Pharmaceuticals, LLC, Boston, MA.; Garcia-Manero G; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.; Fathi AT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Krug, U; Ravandi, F; Ritchie, EK; Sayar, H; Lancet, JE; Craig, MD; Vey, N; Strickland, SA; Schiller, GJ; Jabbour, E; Erba, HP; Pigneux, A; Horst, H-A; Recher, C; Klimek, VM; Cortes, J; Roboz, GJ; Craig, AR; Fox, JA; Ward, R; Smith, JA; Acton, G; Mehta, C; Kantarjian, HM; Stuart, RK

Oncology Research and Treatment. 38

Cortes J; Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, GA, USA.; Jonas BA; Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA.; Schiller G; Department of Internal Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Mims A; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Roboz GJ; Department of Hematology and Medical Oncology, Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA.; Wei AH; Department of Haematology, The Alfred Hospital, Melbourne, Australia.; Montesinos P; Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Ferrell PB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Yee KW; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France.; Schwarer A; Department of Hematology, Box Hill Hospital, Monash University and Eastern Health Clinical School, Melbourne, Australia.; Watts JM; Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Konopleva MY; University of Texas, MD Anderson Cancer Center, Houston, TX. Electronic address: mkonople@mdanderson.org.; Dail M; Genentech, Inc., South San Francisco, CA.; Daver NG; University of Texas, MD Anderson Cancer Center, Houston, TX.; Garcia JS; Dana-Farber Cancer Institute, Boston, MA.; Jonas BA; University of California Davis Comprehensive Cancer Center, Sacramento, CA.; Yee KWL; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Kelly KR; University of Southern California, Los Angeles, CA.; Vey N; Hematologie Clinique, Institut Paoli Calmettes, Marseille, France.; Assouline S; Jewish General Hospital, Montreal, QC, Canada.; Roboz GJ; Weill-Cornell Medical College, New York Presbyterian, New York, NY.; Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Pollyea DA; University of Colorado, Division of Hematology, Aurora, CO.; Tafuri A; Department of Clinical and Molecular Medicine, University Hospital Sant'Andrea-Sapienza, Rome, Italy.; Brandwein JM; Division of Hematology, University of Alberta, Edmonton, AB, Canada.; Pigneux A; Bordeaux Haut-Leveque University Hospital, Pessac, France.; Powell BL; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.; Fenaux P; Hôpital Saint-Louis, Université Paris Diderot, Paris, France.; Olin RL; University of California San Francisco, San Francisco, CA.; Visani G; Hematology, Ospedale San Salvatore, Pesaro, Italy.; Martinelli G; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Onishi M; Genentech, Inc., South San Francisco, CA.; Wang J; Genentech, Inc., South San Francisco, CA.; Huang W; Genentech, Inc., South San Francisco, CA.; Dunshee DR; Genentech, Inc., South San Francisco, CA.; Hamidi H; Genentech, Inc., South San Francisco, CA.; Ott MG; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Hong WJ; Prelude Therapeutics, Wilmington, DE.; Andreeff M; University of Texas, MD Anderson Cancer Center, Houston, TX.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Buckstein R; Department of Medical Oncology/Hematology Sunnybrook Health Sciences Centre Toronto Ontario Canada.; Abel GA; Divisions of Population Sciences and Hematologic Malignancies Dana-Farber Cancer Institute Boston Massachusetts USA.; Giesinger JM; University Hospital of Psychiatry II Medical University of Innsbruck Innsbruck Austria.; Fenaux P; Hôpital Saint Louis Assistance Publique Hôpitaux de Paris and Paris Cité University Paris France.; Bewersdorf JP; Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.; Brunner AM; Leukemia Program, Harvard Medical School Massachusetts General Hospital Cancer Center Boston Massachusetts USA.; Bejar R; Division of Hematology and Oncology, Moores Cancer Center UC San Diego La Jolla California USA.; Borate U; Ohio State University Comprehensive Cancer Center/James Cancer Hospital Ohio State University Columbus Ohio USA.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Hospital Baltimore Maryland USA.; Greenberg P; Department of Medicine, Division of Hematology, Cancer Institute Stanford University School of Medicine Stanford California USA.; Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital New York New York USA.; Savona MR; Department of Medicine, Division of Hematology/Oncology Vanderbilt University Medical Center Nashville Tennessee USA.; Sparano F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Boultwood J; Blood Cancer UK Molecular Haematology Unit, Radcliffe Department of Medicine Nuffield Division of Clinical Laboratory Sciences University of Oxford Oxford UK.; Komrokji R; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sallman DA; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Xie Z; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sanz G; Health Research Institute La Fe, Valencia, Spain Hospital Universitario y Politécnico La Fe Valencia Spain.; Carraway HE; Leukemia Program, Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA.; Taylor J; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Nimer SD; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Della Porta MG; Department of Biomedical Sciences IRCCS Humanitas Clinical and Research Center & Humanitas University Milan Italy.; Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi University of Florence Florence Italy.; Stahl M; Department of Medical Oncology Dana-Farber Cancer Institute and Harvard Medical School Boston Massachusetts USA.; Platzbecker U; Department of Hematology and Cellular Therapy University Hospital Leipzig Leipzig Germany.; Sekeres MA; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine Yale University School of Medicine and Yale Cancer Center New Haven Connecticut USA.

Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE